Federico Hawkins

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Ronald Emkey, Thomas J. Schnitzer et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 547 citations

Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low <scp>IGF</scp> ‐I availability

Andrew Dauber, M.T. Muñoz-Calvo, Vicente Barrios et al. · EMBO Molecular Medicine · 2016 · 208 citations · Full text

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

Matthew Austin, Yuching Yang, Eric Vittinghoff et al. · Journal of Bone and Mineral Research · 2011 · 175 citations · Full text

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 170 citations · Full text